SUSPENDED

HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)

Talk to us

Conditions

Human Papilloma Virus (HPV) VaccineHuman PapillomavirusVaccinationMulti-level interventionCommunity Health CentersBehavioral

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This intervention study will use parent-, provider-, and health center-level strategies to promote HPV vaccination among 11-17 year olds receiving care in 8 community health centers in Florida, will explore factors related to the intervention effect, and will explore implementation outcomes of the intervention.

Official Title

HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)

Quick Facts

Study Start:2023-01-09
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:SUSPENDED

Study ID

NCT05677360

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * For Staff:
  2. * 18 years of age or older
  3. * Working within the participating Federally Qualified Health Center system
  4. * Able to read, write and speak English
  5. * For Providers:
  6. * 18 years of age or older
  7. * Working within the participating Federally Qualified Health Center system
  8. * Interacting with parents of adolescents ages 11-17
  9. * Able to read, write and speak English
  10. * For parents:
  11. * Parent of 11-17 year old child that has received care within the prior two months at one of the participating Federally Qualified Health Centers
  12. * Whose child has not initiated or completed the HPV vaccine series at the time of their last visit
  13. * Able to read, write and speak English or Spanish, or Haitian Creole
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Susan T Vadaparampil, PhD, MPH
PRINCIPAL_INVESTIGATOR
Moffitt Cancer Center
Shannon Christy, PhD
PRINCIPAL_INVESTIGATOR
Moffitt Cancer Center

Study Locations (Sites)

Moffitt Cancer Center
Tampa, Florida, 33612
United States

Collaborators and Investigators

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

  • Susan T Vadaparampil, PhD, MPH, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center
  • Shannon Christy, PhD, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-01-09
Study Completion Date2026-12

Study Record Updates

Study Start Date2023-01-09
Study Completion Date2026-12

Terms related to this study

Keywords Provided by Researchers

  • Human Papillomavirus
  • Vaccination
  • Multi-level intervention
  • Community Health Centers
  • Behavioral

Additional Relevant MeSH Terms

  • Human Papilloma Virus (HPV) Vaccine